Ledger.Open graph →
SEC Form D · filed January 4, 2019

Sun BioPharma, Inc

Offering
$2.0M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WACONIA, MN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Suzanne T. Gagnon · WACONIA, MNDirectorJeffrey S. Mathiesen · WACONIA, MNDirectorJ. R. Paulson, Jr · WACONIA, MNDirectorD. R. Schemel · WACONIA, MNDirectorMichael T. Cullen · WACONIA, MNExec · DirectorPaul W. Schaffer · WACONIA, MNDirectorSusan M. Horvath · WACONIA, MNExecMatthew Nyren · New York, NYDirectorJan E. Frogg · Grand Cayman, Cayman IslandsDirectorDavid Bree · Grand Cayman, Cayman IslandsDirectorCarl Y. Baggett · Dallas, TXDirectorMark E. Stabile · Grand Cayman, Cayman IslandsExec · DirectorColin Mackay · GEORGE TOWN, Grand Cayman, Cayman IslandsDirectorMichael Wasser · Seattle, WADirectorGregory Kris · Chicago, ILDirectorMonroe Capital, Inc · Rochester, NYExec · DirectorBridget Martin · Rochester, NYDirectorPaul Adams · Rochester, NYDirectorLauren Mulholland · Lexington, KYDirectorSusan M. Horvath · WACONIA, MNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗